Full-Time

Technical – CMC

Writer

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior

Remote in USA

Category
Editing & Proofreading
Technical Writing
Content & Writing
Requirements
  • Bachelor’s degree in a scientific or related field required; MS or PhD preferred.
  • 5+ years’ overall experience in technical/CMC writing, 2+ years within Regulatory CMC required.
  • Strong understanding of drug development, drug substance and drug product manufacturing, regulations (CFR, FDA, EMA, and ICH guidelines), and scientific principles.
  • Experience overseeing and mentoring contractors and junior team members strongly preferred.
  • Experience and proficiency with document templates, document toolbars and proper version control.
  • Strong project management skills. Organized and self-motivated. Strong attention to detail.
Responsibilities
  • Lead the compilation, writing, and editing of high-quality module 3 documents.
  • Develop and update pertinent SOPs, processes, templates, style guides, and manuals, as needed.
  • Maintain working knowledge of the Telix development pipeline.
  • Prepare, review, and edit regulatory submission documents (e.g., INDs, NDAs, BLAs, CTDs).
  • Ensure all documents comply with regulatory guidelines, company standards, and industry best practices.
  • Lead and manage multiple regulatory technical writing projects simultaneously, ensuring timely delivery of high-quality documents.
  • Coordinate with cross-functional teams to gather necessary information and resolve any issues that arise during the document development process.
  • Conduct thorough reviews of documents for accuracy, consistency, and clarity as needed.
  • Work closely with clinical development teams, including clinical operations, regulatory affairs, biostatistics, physicians, and medical affairs, to ensure alignment and accuracy of clinical documents.
  • Provide medical writing expertise and support to project teams, contributing to strategic planning and decision-making.
  • Mentor and train junior medical writers, providing guidance and support to enhance their skills and career development, along with oversight to external contractors.
  • Stay current with industry trends, guidelines, and best practices, and share knowledge with the team.
  • Support regulatory submissions by preparing high-quality documentation and addressing health authority comments and queries.
  • Ensure compliance with regulatory requirements and timelines for all submission-related activities.
Desired Qualifications
  • Experience overseeing and mentoring contractors and junior team members strongly preferred.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products for diagnosing and treating cancer and rare diseases using targeted radiation. Their products help healthcare providers make better treatment decisions and offer personalized therapies for conditions that lack effective treatments. The company focuses on areas like prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix has a strong global supply chain to ensure their products are available to healthcare institutions and professionals. Unlike many competitors, Telix emphasizes sustainability, patient care, and ethical practices in its operations. The goal of Telix Pharmaceuticals is to improve the quality of life for patients by providing advanced diagnostic and therapeutic solutions.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Illuccix®'s European approval paves the way for increased revenue in prostate cancer imaging.
  • Acquisition of ImaginAb enhances Telix's innovation capabilities and expands its therapeutic pipeline.
  • Cyclotron capacity expansion in Brussels South boosts production of radioisotopes and patient doses.

What critics are saying

  • Potential delays in Illuccix®'s European launch due to administrative national phase hurdles.
  • Integration challenges from ImaginAb acquisition may disrupt Telix's operations and focus.
  • Dependence on new cyclotron installation in Brussels South could impact production timelines.

What makes Telix Pharmaceuticals unique

  • Telix focuses on molecularly-targeted radiation therapy for prostate, renal, and glioblastoma cancers.
  • The company integrates sustainability and ethical practices into its operations and patient care.
  • Telix's global supply chain ensures worldwide availability of its diagnostic and therapeutic products.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Annual Performance Bonus

Equity-Based Incentive Program

Paid Vacation

Paid Wellness Days

Hybrid Work Options

Remote Work Options